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Background: With the aim of actively contributing to the ongoing 11th International Classification of Diseases (ICD)
revision, an international collaboration led by the European Academy of Allergy and Clinical Immunology (EAACI) has
decided to revise the classification of hypersensitivity/allergic diseases and to validate it for ICD-11 by crowdsourcing
the allergist community. However, understanding that the construction of a classification was necessary but not
sufficient, we developed a mapping strategy in the attempt to better fit it to the ICD-11 linearization structure.
Methods: The cross-linking terms process has been constructed based on an algorithm in which we prioritized
the pre-coordination, followed by the post-coordination when the first step was not possible. If the above strategies
failed to identify the entries, the conditions were ruled as “non specific terms”, “no code fit properly” or “missing terms”.
Results: Amongst the 652 terms distributed in 5 main groups of the Hypersensitivity/Allergic Diseases classification,
169 terms fit directly the codes listed in the ICD-11 beta draft (October 2014 version), 26 were considered as
“nonspecific term”, 21 were linked to the Foundation by Index, 7 were recorded as inclusions and 2 were cited just in
the definition of the condition. The post-coordination was possible for 97 terms, mainly for drug hypersensitivity
conditions. We noticed a considerable number of allergen references missing.
Conclusion: The proposed strategy of cross-linking terms and the results of this process can actively contribute to
updating the hypersensitivity and allergic conditions classification in the ICD-11 beta revision and underlines the
need for either a new chapter in ICD-11 possibly entitled Hypersensitivity / Allergic Disorders or at the very least
the aggregation of all such diseases under the “Diseases of Immune System” chapter in order for the overlaps to
be double parented to the appropriate ‘system’ chapters.
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creativecommons.org/publicdomain/zero/1.0/as to support evidence-based decision-making. It has
created the need for mechanisms and tools to capture,
analyze, interpret and monitor medical data. This need
has given rise to a process of translating the names of
clinical disorders into codes to assist the collection, later
analysis and comparability. However, some recognized cor-
nerstones to achieve a reliable coding system organization
are to have broadly accepted terminologies and a classifica-
tion of clinical disorders able to reflect the clinical practice
and globally endorsed and used by specialists and non-
specialists. Many different coding systems have emerged,
such as the Diagnostic and Statistical Manual of Mentalticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
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broadly the Systematized Nomenclature of Medicine-Clin-
ical Terms (SNOMED-CT) and the International Classifi-
cation of Diseases (ICD). The coding systems have been
constructed under different structures with specific termin-
ologies to facilitate the applicability by distinctive groups of
users [1–3].
The ICD, maintained by the World Health Organization
(WHO), proposes to provide a common language for
reporting and monitoring diseases to achieve the standard
of being a universal classification [1]. However, we have
demonstrated the inadequacy of the ICD-10 and the
current ICD-11 beta phase structures (May and October
2014 versions) to represent the hypersensitivity/allergic
diseases classification, as reported by the allergist commu-
nity [4]. As the most striking example, the ICD-10 showed
to be unable to recognize anaphylaxis deaths as the under-
lying cause of deaths [5] and after a careful comparison
between ICD-10 and 11 beta phase linearization codes we
identified gaps and trade-offs allowing us to bring up the
need of a higher structure for these conditions [3].
The ICD-11 beta draft structure and updates
With the ICD revision, WHO seeks a scientific basis to
ensure comparability and consistency and to allow flexibil-
ity of this tool to be fit for different purposes. The ICD-11
beta draft is an online platform launched in 14th May
2012, which receives constant inputs and is updated regu-
larly. A pre-final version will be tested in real life in 2015.
The final version of the ICD-11 is expected to be pre-
sented to the WHO’s World Heath Assembly in 2017. In
the mean time, the beta phase content is continuously
reviewed by scientific peers and updated accordingly what
permits additions, deletions and changes [6].
The ICD-11 platform has been created based on a
digital library including all ICD entities called Foundation
Component, which is the basis of the construction of a
user-defined list, called Linearization. The Foundation
Component is composed by all attributes of a health con-
dition outlined by a content model and the Linearization
is, therefore, a subset of the Foundation Component built
to fit a particular purpose such as primary care, reporting
morbidity, mortality among other uses. The Linearization
is composed by entities that are mutually exclusive, mean-
ing that each entity receives a single parent and reflects
the final structure of the forthcoming ICD-11 structure.
The ICD conditions listed in the Foundation can be linked
to the online beta draft linearization by Index citation.
The current linearization (October 2014 version) counts
with 26 chapters [1, 6].
Some of the ICD-11 beta draft updates regarding the Al-
lergy and Clinical Immunology field included the creation
of a “Diseases of the Immune System” chapter (first no-
ticed in May, 2014) and a code for Allergy and allergicreactions (ND51.2 last viewed in the ICD-11 linearization
November version) under the “External Causes” chapter.
After sharing the classification of hypersensitivity/allergic
diseases with representatives of Dermatology, Rare Dis-
eases, Pediatric, Internal Medicine and Ophthalmology
Topic Advisory Groups (TAGs) (July 2014), more im-
provements in relation to Allergy have been noticed, such
as (1) a formal proposal to add a category for conditions
due to adverse immune response into the “Diseases of the
Immune System” chapter from multiple parented primary
locations, if relevant and (2) to include categories such as
‘food allergy’ or ‘adverse food reaction (September 2014).
Terminologies for hypersensitivity/allergic diseases
“Terms” are words or group of words responsible for pro-
viding a specific meaning according to the context they
are used, being able to be considered stable identifiers.
“Nomenclature” is a system of terms, constructed accord-
ing to a specific rule, in a particular field of science, mak-
ing possible labeling and designating concepts. When a
term is created, a set of words is coordinated together into
a concept to represent some piece of relevant information.
Based on the similarities and differences of the condi-
tions, which receives terms, it is possible to delineate a
classification. However, the terms have to be adapted
according to the end-users of the classification. In this
way, the EAACI-WAO survey of health professionals’
attitudes toward allergic disorders classification [4] dem-
onstrated the need of a global cross-culturally applicable
classification system of allergic diseases.
In the Allergy specialty, the constant generation of new
knowledge forces the update of concepts and, therefore, no-
menclature/terms; in this regard the above survey showed
that the EAACI-WAO revised nomenclature [7] is accepted
by the majority of the allergist community. Based on that,
“hypersensitivity” is defined as “conditions clinically resem-
bling allergy that cause objectively reproducible symptoms
or signs, initiated by exposure to a defined stimulus at a
dose tolerated by normal subjects” and “allergy” as “a
hypersensitivity reaction initiated by immunologic mecha-
nisms”. However, this distinction is still not used by non-al-
lergists and non-physicians; consequently, the solution we
used was always to link the terms hypersensitivity and al-
lergy. Although we are aware of the importance of im-
munological diseases including immune deficiencies and
autoimmune disorders, these conditions were not in-
corporated into the current document since the ICD-11
has already dedicated a chapter for these disorders enti-
tled “Immune System Disorders” [6].
The new classification of hypersensitivity/allergic diseases
With the aim of actively contributing to the ongoing 11th
ICD revision, an international collaboration led by the
European Academy of Allergy and Clinical Immunology
Fig. 1 General structure of the Hypersensitivity/Allergic Classification for ICD-11 validated by crowdsourcing the allergist experts
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sensitivity/allergic diseases and to validate it for ICD-11 by
crowdsourcing the leaderships of the major allergy societies
across the world, experts in allergy, terminology leaders and
end-users [8]. As a result, a high level complex structure of
classification for hypersensitivity/allergic diseases has been
constructed with 10 main categories of hypersensitivity/Fig. 2 Algorithm of Interactive Mapping Assistance Generation of Allergic Dallergic diseases covering respiratory (asthma and rhinitis),
skin (dermatitis, urticaria and angioedema), ocular (con-
junctivitis), drug, food and Hymenoptera venom allergies
and anaphylaxis distributed in 5 main groups (Fig. 1). The
document has been shared with a SNOMED CT termin-
ology expert, Topic Advisory Group (TAGs) and the Revi-
sion Steering Group (RSG) representatives in charge of theiseases ICD Codes strategy
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ing out from the beginning bilateral discussion to have the
endorsement of the classification proposal for the ICD-11.
Advised by representatives of some TAGs and the RSG
and believing that more than offering the classification
proposal, we could contribute to aligning the hypersensi-
tivity/allergic diseases classification to the ICD-11 beta
draft linearization facilitating the classification proposal
acceptance, we here propose the process of mapping the
constructed classification of hypersensitivity/allergic in
the current ICD-11 beta draft linearization (October
2014 version) by cross-linking terms and highlighting
the unmet needs.
Methods
Interactive mapping of hypersensitivity/allergic diseases
in the ICD-11
Methods to build the cross-linking terms
Understanding that the construction of a classification of
hypersensitivity/allergic diseases by crowdsourcing the al-
lergy community was necessary but not sufficient, we have
addressed the question of how to fit the hypersensitivity/
allergic diseases entries to the current ICD-11 framework.
To answer this query, we developed a search strategy
(Figs. 2 and 3). For that, the published classification pro-
posal [8] and the online ICD-11 beta draft linearization
framework (October 2014 version) [6] were considered as
the basis of the searching process. We carefully looked at
all the terms of the validated hypersensitivity/allergicFig. 3 General scheme of the classification strategydiseases classification, checked if they were cited in the
ICD-11 beta draft and classified the terms as able to “pre-
coordination”, “post-coordination”, “non-specified term”,
“no code fit properly” and “missing term”.
In the first step of the process, believing that all hyper-
sensitivity/allergic diseases deserve their own codes, the
pre-coordination was prioritized. In this way, all possible
corresponding codes for each hypersensitivity/allergic
condition described in the classification proposal were
listed according to the algorithm shown on Fig. 1. “Pre-
coordination” is the fixed elements into one heading in
anticipation of a search on that compound heading. It is
needed to avoid disambiguation and/or suggestibility be-
sides facilitating an accurate search in a health classifica-
tion system. The pre-coordination is preferable once the
most useful mappings are the one-to-one maps, in which
a single hypersensitivity/allergic concept can be used to
represent the full meaning of an ICD-11 beta draft code/
term. This allows the automatic translation of Hypersen-
sitivity/allergic conditions into ICD-11 codes without
loss of meaning.
In cases in which pre-coordination was not possible,
post-coordination was considered. “Post-coordination” is
the combining or adding to an existing entity or keyword
additional details to provide greater specificity to the en-
tity. These additional details can provide more informa-
tion such as severity, causality, mechanism and anatomy.
The basis of the combining process usually obeys the rec-
ommendations of the WHO and the Library of Congress
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can be constructed from individual elements that represent
clinical presentation, cause, site or underlining mechanism
(e.g., “drug induced-anaphylaxis” as the condition + “Peni-
cillin” as the cause). In practice, it can be used for complex
and multi-element conditions to achieve coverage; however,
without some rational grammar an end-user can post-
coordinate an invalid notion from the available parts.
If the above strategies failed to identify the hypersensitiv-
ity/allergic entries, the conditions were labeled as “non spe-
cific terms” when the existent term was too generic or able
to cover many different conditions, such as the “catch-all”
codes that encompass heterogeneous diseases or condi-
tions (e.g., “other specified papillary conjunctivitis”). We
considered as “missing terms” cases in which the corre-
sponding terms were completely absent, and “no code fit
properly” when the ICD-11 classification did not cover
exactly the hypersensitivity/allergic condition (e.g., KA04.1Table 1 Mapping the terms “hypersensitivity” and “allergy” in the IC




“Hypersensitivity” “Conditions clinically resembling allergy that
cause objectively reproducible symptoms or
signs, initiated by exposure to a defined stimulus

























“AllergyNeonatal eosinophilic oesophagitis” for Food-induced eo-
sinophilic esophagitis).
All the process of searching the key terms correspon-
dences into the ICD 11-beta draft platform (October 2014
version) had an online basis. It was, then validated by LKT
and PD and cross-checked to avoid disambiguation and
dubious interpretation of data. We are, however, aware
that the definitive codification is not established in the
linearization up to now.Results and discussion
Results of the cross-linking terms process
Considering the main definitions of “hypersensitivity” and
“allergy”, we first looked for these terms in the online
ICD-11 beta draft. As a result, we observed that both
terms are currently listed 9 times each across the ICD-11
structure (Table 1).D-11 beta draft structure (October 2014 version)
Beta draft search
er 2014 version)
Location according to the
Linearization (October 2014 version)
ensitivity reactions” Under the “Disorders of
lymphocyte number” subchapter
ensitivity myocarditis” Under the “Diseases of the
myocardium” chapter
ensitivity pneumonitis due to
dust”
Under the “Pneumonia” subchapter
specific hypersensitivity
onitis due to organic dust”
ensitivity pneumonitis due to
dust, unspecified”




Listed as an Inclusion of “DRESS
Syndrome”
ensitivity NOS” Listed as an Inclusion of “Adverse
effects, not elsewhere classified”
sts for: hypersensitivity” Cited as an Inclusion of “Diagnostic skin
and sensitization tests”
to substances in contact with
”
Under the “Skin disorders provoked by
external factors” subchapter
lergy syndrome” Under the “Allergy to substances in
contact with the skin” subchapter
specified forms of cutaneous
or allergic reaction” Under the “Adverse effects, not
elsewhere classified” subchapter
NOS due to pollen” Under the “Vasomotor and allergic
rhinitis” subchapter
-food allergy syndrome” Cited as an Inclusion of “Oral allergy
syndrome”
llergy Cited as an Inclusion of “Allergy or
allergic reaction”
tests” Cited as an Inclusion of “Diagnostic skin
and sensitization tests”
Table 2 Cross-linking terms process: numbers of terms per main group of hypersensitivity/allergic diseases by pre and post-coordination,
considered unspecific or did not fit properly to the ICD-11 beta draft (October 2014 version)
Main groups of Hypersensitivity/Allergic Diseases










N (%) N (%) N (%) N (%) N (%) N (%)
Respiratory diseases (124 terms) 36 (29) 0 (0) 3 (2) 15 (12) 11 (9) 12 (10)
Ocular diseases (55 terms) 20 (36) 2 (4) 0 (0) 6 (11) 5 (9) 5 (9)
Skin diseases (149 terms) 63 (42) 17 (11) 4 (3) 9 (6) 0 (0) 0 (0)
Digestive diseases (28 terms) 1 (4) 0 (0) 0 (0) 0 (0) 8 (29) 0 (0)





26 (22) 2 (2) 0 (0) 53 (45) 7 (6) 0 (0)
Hymenoptera hypersensitivity
(18 terms)
3 (17) 0 (0) 0 (0) 0 (0) 2 (11) 0 (0)
Food hypersensitivity
(74 terms)
15 (20) 0 (0) 0 (0) 0 (0) 9 (12) 2 (3)
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cation [8] counts with a total of 652 terms distributed in 5
main groups: Hypersensitivity/Allergic disorders involving
the eye and the respiratory tract (179 terms), Hypersensi-
tivity/Allergic disorders involving the skin and mucous
membranes (149 terms), Hypersensitivity/Allergic disor-
ders involving the digestive tract (28 terms), Anaphylaxis
(85 terms) and Complex hypersensitivity/allergic disorders
(119 terms for drug hypersensitivity, 18 terms Hymenop-
tera hypersensitivity and 74 terms for food hypersensitiv-
ity). Table 2 shows the results of the cross-linking terms
process, in which 169 terms fit directly those classifica-
tions/codes listed in the ICD-11 beta draft (October 2014
version), and 26 were considered as “non-specific term”.
Twenty-one terms could be linked to the Foundation by
accessing the link Index, 7 were recorded as inclusions andFig. 4 Proportion of missing terms for each hypersensitivity/allergic disease2 were cited just in the definition of the condition. The
post-coordination was possible for 97 terms, mainly for
drug hypersensitivity conditions. The proportion of the
missing terms for hypersensitivity/allergic diseases main
groups was the highest for Hymenoptera hypersensitivity
and digestive diseases (Fig. 4).
Challenges of the cross-linking terms process
Improvements have been observed in the classification of
some conditions in ICD-11 beta draft (October 2014 ver-
sion) when compared to the ICD-10; however, the terms
“hypersensitivity” and “allergy” are still misclassified in the
ongoing revision, meaning that these concepts used rou-
tinely by the allergist community are still not globally ac-
cepted and may even be confusing. Both terms are in use
mainly to describe specific conditions. It is notable thats group in the ICD-11 beta draft (October 2014 version)




Results of searching process in the ICD-11 beta phase
(October 2014 version)
“Mite” “Infestation by mites”
“Infestation of the skin by other specified parasitic mites”
“Scrub (mite-borne) typhus”
“Milk” “Intestinal obstruction due to inspissated milk”
“Fetus and newborn affected or suspected to be affected
by noxious influence transmitted via placenta or breast milk”
“Other specified fetus and newborn affected or suspected
to be affected by noxious influences transmitted via placenta
or breast milk”
“Fetus and newborn affected or suspected to be affected by
noxious influence transmitted via placenta or breast milk,
unspecified”
“Neonatal aspiration of milk and regurgitated food”
“Neonatal aspiration of milk and regurgitated food with
respiratory symptoms”
“Other specified neonatal aspiration of milk and regurgitated
food”
“Neonatal aspiration of milk and regurgitated food,
unspecified”
“Neonatal hyperbilirubinemia due to breast milk inhibitor of
bilirubin conjunction”






“Assault: Contact with person, animal or plant: Bitten,
scratched or stung, non-venomous: Insect or bird”
“Intentional Self Harm: Contact with person, animal or plant:
Bitten, scratched or stung, non-venomous: Insect or bird”
“Undetermined intent: Contact with person, animal or plant:
Bitten, scratched or stung, non-venomous: Insect or bird”
“Intent pending: Contact with person, animal or plant: Bitten,
scratched or stung, non-venomous: Insect or bird”
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fects, not elsewhere classified (NOS)” meaning that it can
be considered synonymous. It is also observed that the
“hypersensitivity reactions” are considered disorders ex-
clusively related to the lymphocytes number (Table 1). On
the other hand, “Allergy or allergic reaction” is classified
both as an inclusion, synonymous of “Hypersensitivity
NOS”, “Idiosyncrasy NOS”, “Anaphylaxis NOS”, “Allergic
shock NOS”, and under the same subchapter. On top of
that, “Allergy or allergic reaction” excludes “Urticaria, an-
gioedema and other urticarial disorders” from its panel al-
though urticaria and angioedema can be IgE-mediated
(allergen-induced) and are possible manifestations of
anaphylaxis.
The cross-linking terms process demonstrated that some
specific groups of hypersensitivity/allergic disorders, such
as skin, ocular and drug hypersensitivities, fit better the
current ICD-11 framework than other groups (e.g., anaphyl-
axis, food and hymenoptera hypersensitivities) (Table 2),
which probably reflects the specific work of the related
TAGs. Regarding drug hypersensitivity, most of the condi-
tions could be classified by post-coordination terms (e.g.,
“Anaphylaxis due to systemic antibiotics” was classified by
FN32.3 Drug-induced anaphylaxis + PC70 Systemic antibi-
otics or “Angioedema due to angiotensin converting
enzyme (ACE) inhibitor” classified by FA75 Angioedema +
PC7C.5 Angiotensin-converting-enzyme inhibitors).
The proportion of terms classified as “no code fit prop-
erly” was higher for hypersensitivity/allergic disorders of
the digestive tract, which included exclusively digestive
manifestations of food hypersensitivity. As an example,
the result of searching “food-induced eosinophilic esopha-
gitis” was “KA04.1 Neonatal eosinophilic oesophagitis”.
For respiratory hypersensitivity/allergic disorders, we ob-
served a higher number of terms considered as “nonspe-
cific”, with excessive generic extension and interpretation
or able to cover many different conditions. The code/classi-
fication “DA05.Y Other specified vasomotor and allergic
rhinitis” covered both Allergic and Non-allergic rhinitis
such as Local Allergic Rhinitis, all Occupational Rhinitis
(both caused and exacerbated by work), Rhinitis of the eld-
erly, Gustatory Rhinitis, Hormonal-induced rhinitis and
drug-induced rhinitis.
Unmet needs of the cross-linking terms process for
hypersensitivity/allergic diseases
The proportion of missing terms was notable for food, re-
spiratory and hymenoptera venom hypersensitivity, mainly
for the absence of disorder descriptions and lack of aller-
gen references in the ICD-11 framework.
The considerable number of allergen references missing
precludes even the post-coordination process. Most of im-
portant allergens diagnosed in the daily clinical practice of
the allergist, such as (house) dust mite or milk, are absentor misclassified (Table 3). In the respiratory hypersensitiv-
ity/allergic disorders field, the only condition able to be
properly cross-linked by pre-coordination mentioning an
allergen is “DA05.2 Allergic rhinitis due to pollen”. For
food allergens, the misclassification is remarkable. When
we searched for the term “milk”, the conditions listed are
basically related to mechanical injuries (e.g., aspiration)
and when the search is refined to “milk allergy”, no result
is found. More than underlying the need of the inclusion
of these terms in the new ICD edition, the current paper
calls attention for the importance of involving the Allergy
specialty in the revision process.
For anaphylaxis, 40 % of terms were missing and the
search of the term “anaphylaxis” in the ICD-11 beta draft
showed 4 descriptions, mainly related to drug allergy: “drug-
induced urticarial, angioedema and anaphylaxis”, “drug-
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due to medication in proper dose”. There are no references
related with the severity grade of this condition or other
associated allergies, which differs from the published
Hypersensitivity/Allergic Diseases classification [7]. Fur-
thermore, as highlighted before [4], anaphylaxis still resides
under the same nonspecific “Injury, poisoning and certain
other consequences of external causes” chapter, although
some related conditions are described in other chapters
such as “anaphylaxis due to contrast media” listed into the
“Miscellaneous of urticarial disorders” of the Skin Disor-
ders chapter.
All the conditions classified as “non specific term” and
“no code fit properly” hamper the possibility of a better
classification of hypersensitivity/allergic disorders, driving
to the misclassification already highlighted in the ICD-10
structure. It suggests the need for updating and including
more specific terms able to cover these conditions.
Critical view of the cross-linking terms process for
hypersensitivity/allergic diseases
Mapping is a labor-intensive process and needs to be up-
dated regularly once the ICD-11 beta draft structure is notFig. 5 The Joint Allergy Academies strategies for a better classification of hdefinite. One recognized limitation of this process is the
possibility of broad interpretation for some terms, which
can hamper the consistency of the classification system. In
this way, the terms considered as “non specific” and “no
code fit properly” may have to be tuned to better fit the
purpose of a better classification for Hypersensitivity/Al-
lergic diseases.
Since the online ICD-11 beta draft platform is not final
and is updated regularly, the current results may not be
reproduced if taken in a different time of analysis with the
same methodology. Although this manuscript presents
technical aspects of nomenclature and classification, we
intended to introduce and simplify the complex concepts
with the aim of becoming more familiar to the allergy
community ICD end-users.
The results presented underline evidences of the need
for changes in the ICD-11 framework and provides a base-
line to expected improvements to allow the recognition of
the diseases covered by the Allergy specialty. Although we
are aware of the enormous structural changes and efforts
needed to this end, having Hypersensitivity/allergic dis-
eases well classified in the ICD-11 may have important
impact for the visibility of our specialty. It is important toypersensitivity/allergic diseases in the ICD-11
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priately coded health data are important for a number of
clinical reasons. The most important clinical utility of
coded information is to support appropriate computerized
decision support around ordering investigations, medi-
cines management and bundling of care, and related per-
formance management.
The current manuscript had the hypersensitivity/allergic
diseases classification validated by crowdsourcing as the
basis for its construction. Since the crowdsourcing process
has been supported and acknowledged by a Joint Allergy
Academies, composed by the EAACI, the World Allergy
Organization (WAO) and the American Academy of
Asthma Allergy and Clinical Immunology (AAAAI), we
believe that the expected implementations in the ICD-11
by the allergy perspective (Fig. 5) will count with a harmo-
nized point of view.Conclusions
Outcomes of the cross-linking terms process for the
hypersensitivity/allergic diseases
Many of the Hypersensitivity/Allergic diseases classification
terms contain clinical information encoded in the ICD-11
beta draft and the cross-linking process was possible by
pre-coordination to some conditions in detriment to spe-
cific ones in which the post-coordination fit better. How-
ever, we still notice an important degree of missing and
“non specific” terms.
The unspecific results of searching “hypersensitivity” and
“allergy” terms demonstrate that the Allergy specialty has
still concepts not universally accepted. The Allergy specialty
involvement in the current revision would contribute to up-
grade the awareness of the hypersensitivity/allergic condi-
tions in the ICD revision.
The proposed strategy of cross-linking terms and the re-
sults of this process can actively contribute to updating the
hypersensitivity and allergic conditions classification in the
ICD-11 beta revision by objectively demonstrating which
entries can fit the ongoing ICD-11 structure, indicating the
categories which should be improved to have a reliable un-
derstanding as well as bringing up the missing categories.
The results of the process underline the need for either a
new chapter in ICD-11 possibly entitled Hypersensitivity /
Allergic Disorders or at the very least the aggregation of all
such diseases under the “Diseases of Immune System”
chapter in order for the overlaps to be double parented to
the appropriate ‘system’ chapters.
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